Home › NDC Lookup › RxCUI directory › RxCUI 310386

Fluoxetine 4 MG/ML Oral Solution — RxCUI 310386

RxNorm drug concept · Semantic clinical drug
RxCUI 310386 Semantic clinical drug · SCD ● Current RxNorm concept 10 FDA products 11 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI310386
Official nameFluoxetine 4 MG/ML Oral Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asfluoxetine 20 MG per 5 ML Oral Solution; FLUoxetine 20 MG in 5 mL Oral Solution; fluoxetine 4 MG/ML (as fluoxetine HCl) Oral Solution
FDA products mapped10
Package NDCs mapped11
Reported Medicaid activity (SDUD)137,350 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Fluoxetine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Most people don't feel a noticeable difference right away — that's completely normal. It typically takes several weeks to start feeling the full benefit, and some people need a few...
  • How long does it take for fluoxetine to actually start working?
  • It's really important not to stop on your own, even if you feel great. Stopping suddenly can cause discontinuation symptoms, and your condition may come back. The good news is that...
  • Can I stop taking fluoxetine if I start feeling better?
📖 Read our full Fluoxetine guide →

🕸️ Concept Web — How Fluoxetine 4 MG/ML Oral Solution Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Fluoxetine 4 MG/ML Oral Solution RxCUI 310386

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Fluoxetine 4493
  2. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Fluoxetine Oral Solution 372232
    • Fluoxetine Oral Liquid Product 1160835
    • Fluoxetine Oral Product 1160836
    • Oral Solution 316968
    • Oral Liquid Product 1151137
    • Oral Product 1151131
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Fluoxetine 4 MG/ML 315953

Showing up to 8 concepts per family — 8 of 8 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Fluoxetine 4 MG/ML SCDC · 315953
  • Fluoxetine Oral Solution SCDF · 372232
  • Fluoxetine Oral Liquid Product SCDG · 1160835
  • Fluoxetine Oral Product SCDG · 1160836

📦 FDA Products & Package NDCs

10 products · 11 package NDCs
11 package NDCs map to RxCUI 310386 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00121-0721-04 120 mL in 1 BOTTLE (0121-0721-04) Fluoxetine PAI Holdings, LLC dba PAI Pharma 2002-01-30
00121-4721-40 4 TRAY in 1 CASE (0121-4721-40) / 10 CUP, UNIT-DOSE in 1 TR... Fluoxetine PAI Holdings, LLC dba PAI Pharma 2002-02-01
00832-6032-12 1 BOTTLE in 1 CARTON (0832-6032-12) / 120 mL in 1 BOTTLE Fluoxetine hydrochloride Upsher-Smith Laboratories, LLC 2022-11-30
54838-0523-40 120 mL in 1 BOTTLE, PLASTIC (54838-523-40) Fluoxetine Lannett Company, Inc. 2009-08-27
60687-0845-77 4 TRAY in 1 CASE (60687-845-77) / 10 CUP, UNIT-DOSE in 1 TR... Fluoxetine American Health Packaging 2024-12-04
62135-0730-24 2 TRAY in 1 BOX (62135-730-24) / 10 CUP in 1 TRAY / 5 mL in... Fluoxetine Chartwell RX, LLC 2024-05-23
62135-0730-41 120 mL in 1 BOTTLE (62135-730-41) Fluoxetine Chartwell RX, LLC 2023-09-27
65862-0306-12 120 mL in 1 BOTTLE, GLASS (65862-306-12) Fluoxetine Aurobindo Pharma Limited 2009-03-19
68999-0730-24 2 TRAY in 1 BOX (68999-730-24) / 10 CUP in 1 TRAY / 5 mL in... Fluoxetine Chartwell Governmental & Specialty RX, LLC 2025-10-31
70954-0600-10 120 mL in 1 BOTTLE, PLASTIC (70954-600-10) Fluoxetine Hydrochloride ANI Pharmaceuticals, Inc. 2022-11-09
71656-0089-04 120 mL in 1 BOTTLE (71656-089-04) FLUOXETINE Saptalis Pharmaceuticals, LLC. 2025-06-20
Observed labelers: Chartwell RX, LLC (2) · PAI Holdings, LLC dba PAI Pharma (2) · American Health Packaging (1) · ANI Pharmaceuticals, Inc. (1) · Aurobindo Pharma Limited (1) · Chartwell Governmental & Specialty RX, LLC (1) · +3 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.